SCHEMBL5753142

SCHEMBL5753142

O=C(CCc1ccccc1)NC(Cc1ccc(C(F)(F)F)cc1)C(O)c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 1/20 0.53
EPHX2 P34913 1/20 0.53
FFAR2 O15552 1/20 0.49
UTS2R Q9UKP6 3/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CYP2C19 P33261 1/20 0.48
MAPK14 Q16539 2/20 0.47
CNR2 P34972 1/20 0.47
FFAR1 O14842 4/20 0.46
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
HDAC1 Q13547 1/20 0.44
PLAAT3 P53816 1/20 0.43
PLAAT5 Q96KN8 1/20 0.43
PLAAT2 Q9NWW9 1/20 0.43
PLAAT4 Q9UL19 1/20 0.43
FNTA P49354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5755621 0.91 FFAR1 (0.48) LTA4HEPHX2FFAR2UTS2RCYP1A2
SCHEMBL5751228 0.91 CYP1A2 (0.49) FFAR2UTS2RCYP1A2CYP3A4CYP2C9
SCHEMBL5753990 0.91 FFAR2 (0.55) FFAR2UTS2RCYP1A2CYP3A4CYP2C9
SCHEMBL5750097 0.89 LTA4H (0.50) LTA4HEPHX2CNR2FFAR1PPARG
SCHEMBL5753673 0.89 FFAR2 (0.52) FFAR2UTS2RCYP1A2CYP3A4CYP2C9
SCHEMBL5749304 0.84 FFAR2 (0.49) FFAR2UTS2RCYP1A2CYP3A4CYP2C9
SCHEMBL5755551 0.83 LMNA (0.49) FFAR2UTS2RCYP1A2CYP3A4CYP2C9
SCHEMBL5751792 0.83 LMNA (0.49) FFAR2UTS2RCYP1A2CYP3A4CYP2C9
SCHEMBL5750365 0.82 FFAR2 (0.49) FFAR2UTS2RCYP1A2CYP3A4CYP2C9
SCHEMBL5752196 0.82 MAPK14 (0.55) LTA4HEPHX2CYP3A4MAPK14CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6982348-B2 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-01-03 US disclosed
US-20040127574-A1 Aminoethanol derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-07-01 US disclosed
EP-1362846-A1 AMINOETHANOL DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040127574-A1 Aminoethanol derivatives CETP, LCAT, MTTP LTA4H 1060/4885EPHX2 1434/4885FFAR2 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.